1. Home
  2. CYTK vs DOX Comparison

CYTK vs DOX Comparison

Compare CYTK & DOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$68.45

Market Cap

8.0B

Sector

Health Care

ML Signal

HOLD

Logo Amdocs Limited

DOX

Amdocs Limited

HOLD

Current Price

$76.40

Market Cap

8.5B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYTK
DOX
Founded
1997
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
8.0B
8.5B
IPO Year
2004
1998

Fundamental Metrics

Financial Performance
Metric
CYTK
DOX
Price
$68.45
$76.40
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
15
3
Target Price
$77.87
$97.00
AVG Volume (30 Days)
1.9M
1.2M
Earning Date
11-05-2025
11-11-2025
Dividend Yield
N/A
2.98%
EPS Growth
N/A
18.92
EPS
N/A
5.05
Revenue
$87,211,000.00
$4,532,913,000.00
Revenue This Year
$363.61
$5.03
Revenue Next Year
$64.33
$5.25
P/E Ratio
N/A
$15.14
Revenue Growth
2609.26
N/A
52 Week Low
$29.31
$74.32
52 Week High
$69.33
$95.41

Technical Indicators

Market Signals
Indicator
CYTK
DOX
Relative Strength Index (RSI) 62.93 38.04
Support Level $59.85 $74.45
Resistance Level $67.98 $76.35
Average True Range (ATR) 2.72 2.16
MACD 0.13 -0.20
Stochastic Oscillator 91.35 18.48

Price Performance

Historical Comparison
CYTK
DOX

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About DOX Amdocs Limited

Amdocs Ltd is a provider of software and services to communications, cable and satellite, entertainment, and media industry service providers. The Company and its subsidiaries operate in one operating segment, providing software products and services for the communications, entertainment and media industry service being designed, develop, market, support, implement, and operate its open and modular cloud offering. The company offers business support systems, operational support systems, and managed services. Geographically, it derives a majority of revenue from North America and also has a presence in Europe and the Rest of the world.

Share on Social Networks: